Back to Search
Start Over
The role of fibroblast growth factor-2 in modulating the differentiation of periodontal ligament and alveolar bone-derived stem cells.
- Source :
-
Archives of oral biology [Arch Oral Biol] 2024 Sep; Vol. 165, pp. 106027. Date of Electronic Publication: 2024 Jun 08. - Publication Year :
- 2024
-
Abstract
- Objective: This study examined how range concentrations of Fibroblast Growth Factor-2 (FGF-2) influence the differentiation and activity of human-derived periodontal ligament (hPDLSCs) and alveolar bone-derived stem cells (haBMSCs).<br />Design: hPDLSCs and haBMSCs were cultured with varying concentrations of FGF-2 (0, 1, 2.5, 5, 10, 20 ng/mL) and monitored for osteogenic differentiation through alkaline phosphatase (ALP) activity and quantification of gene expression (qRT-PCR) for osteogenesis markers. Additionally, alizarin red staining and a hydroxyproline colorimetric assay evaluated and quantified osteogenic matrix mineralization and collagen deposition. Statistical analyses were performed using one-way ANOVA or two-way ANOVA for multiple comparisons between groups.<br />Results: At low FGF-2 concentrations, hPDLSCs differentiated toward an osteogenic lineage, whereas higher concentrations of FGF-2 inhibited osteogenesis and promoted fibroblastic differentiation. The effect of FGF-2 at the lowest concentration tested (1 ng/mL) led to significantly higher ALP activity than osteogenically induced positive controls at early time points and equivalent RUNX2 expression at early and later time points. FGF-2 supplementation of haBMSC cultures was sufficient, at all concentrations, to increase ALP activity at an earlier time point. Mineralization of haBMSC cultures increased significantly within 5-20 ng/mL FGF-2 concentrations under basal growth media conditions (α-minimal essential medium supplemented with 15 % fetal bovine serum and 1 % penicillin/streptomycin).<br />Conclusions: FGF-2 has a dual capacity in promoting osteogenic and fibroblastic differentiation within hPDLSCs contingent upon the dosage and timing of administration, alongside supporting osteogenic differentiation in haBMSCs. These findings underscore the need for precision growth factors dosing when considering the design of biomaterials for periodontal regeneration.<br />Competing Interests: Declaration of Competing Interest The authors declare that they have no financial or personal interests that compete with the outcomes presented in this paper.<br /> (Copyright © 2024 Elsevier Ltd. All rights reserved.)
- Subjects :
- Humans
Alkaline Phosphatase metabolism
Alveolar Process cytology
Alveolar Process drug effects
Cell Differentiation drug effects
Cells, Cultured
Core Binding Factor Alpha 1 Subunit metabolism
Osteogenesis drug effects
Osteogenesis physiology
Real-Time Polymerase Chain Reaction
Stem Cells drug effects
Fibroblast Growth Factor 2 pharmacology
Periodontal Ligament cytology
Periodontal Ligament drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 1879-1506
- Volume :
- 165
- Database :
- MEDLINE
- Journal :
- Archives of oral biology
- Publication Type :
- Academic Journal
- Accession number :
- 38870610
- Full Text :
- https://doi.org/10.1016/j.archoralbio.2024.106027